|
ZNF256 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.925600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.567700E-02 |
| Normal-vs-Stage2 |
7.984300E-02 |
| Normal-vs-Stage3 |
1.381040E-03 |
| Normal-vs-Stage4 |
1.92306999999836E-05 |
| Stage1-vs-Stage2 |
6.179600E-01 |
| Stage1-vs-Stage3 |
6.059700E-02 |
| Stage1-vs-Stage4 |
7.143800E-03 |
| Stage2-vs-Stage3 |
2.850000E-01 |
| Stage2-vs-Stage4 |
2.406400E-02 |
| Stage3-vs-Stage4 |
1.077970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.175600E-02 |
| Normal-vs-AfricanAmerican |
4.106000E-01 |
| Normal-vs-Asian |
5.186200E-02 |
| Caucasian-vs-AfricanAmerican |
4.573800E-01 |
| Caucasian-vs-Asian |
4.356600E-01 |
| AfricanAmerican-vs-Asian |
3.918000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.053660E-02 |
| Normal-vs-Female |
7.529400E-01 |
| Male-vs-Female |
3.809900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.962800E-01 |
| Normal-vs-Extreme_Weight |
1.220470E-02 |
| Normal-vs-Obese |
2.971000E-01 |
| Normal-vs-Extreme_Obese |
6.501400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.468600E-01 |
| Normal_Weight-vs-Obese |
8.408400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.639600E-01 |
| Extreme_Weight-vs-Obese |
2.559200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.264000E-01 |
| Obese-vs-Extreme_Obese |
9.440600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.663400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.265200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.120300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.334010E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.181400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.014200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.870000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.858600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.904560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.435000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.289000E-01 |
| Normal-VS-Type2 PRCC |
3.88470000000085E-05 |
| Normal-VS-KIRP CIMP |
2.760200E-01 |
| Normal-VS-Unclassified PRCC |
1.167790E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.7998699999966E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.195600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.579400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.621800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.301670E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.807200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.962700E-04 |
| Normal-vs-N1 |
1.528400E-01 |
| Normal-vs-N2 |
3.642400E-04 |
| N0-vs-N1 |
5.852200E-01 |
| N0-vs-N2 |
3.019600E-04 |
| N1-vs-N2 |
3.922700E-03 |
|
|
